Published in J Infect Dis on November 01, 1995
Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis (2000) 1.82
Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A (1998) 1.45
Parvovirus B19-induced apoptosis of hepatocytes. J Virol (2004) 1.26
Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations. J Clin Pathol (2006) 1.18
Gangliosides are essential for bovine adeno-associated virus entry. J Virol (2006) 1.17
Glycosphingolipid functions. Cold Spring Harb Perspect Biol (2011) 1.02
Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect Immun (1998) 0.99
Glycosphingolipids as receptors for non-enveloped viruses. Viruses (2010) 0.98
Chronic hepatitis caused by persistent parvovirus B19 infection. BMC Infect Dis (2010) 0.91
Parvovirus glycan interactions. Curr Opin Virol (2014) 0.90
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Replication of Aleutian mink disease parvovirus in vivo is influenced by residues in the VP2 protein. J Virol (1999) 0.87
Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection. Adv Exp Med Biol (2013) 0.84
Chemoenzymatic Syntheses of Tumor-Associated Carbohydrate Antigen Globo-H and Stage-Specific Embryonic Antigen 4. Adv Synth Catal (2008) 0.83
Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation. Biol Blood Marrow Transplant (2008) 0.83
Parvovirus b19 associated hepatitis. Hepat Res Treat (2013) 0.79
Quantifying lipid contents in enveloped virus particles with plasmonic nanoparticles. Small (2014) 0.79
Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice. Virulence (2015) 0.79
Infection with Parvovirus B19. Curr Infect Dis Rep (1999) 0.78
Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion. Med J Islam Repub Iran (2015) 0.76
Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation. BMC Nephrol (2016) 0.75
Severe Aplastic Anemia following Parvovirus B19-Associated Acute Hepatitis. Case Reports Hepatol (2017) 0.75
Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children. World J Clin Pediatr (2015) 0.75
Infection-Related Focal Segmental Glomerulosclerosis in Children. Biomed Res Int (2016) 0.75
Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor. Infect Dis Obstet Gynecol (2004) 0.75
Concurrent comparison of the safety of paid cytapheresis and volunteer whole-blood donors. Transfusion (1994) 3.52
T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. J Immunol (1986) 1.62
Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts. Arthritis Rheum (2001) 1.47
Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med (1989) 1.40
High-resolution proton NMR studies of gangliosides. 1. Use of homonuclear two-dimensional spin-echo J-correlated spectroscopy for determination of residue composition and anomeric configurations. Biochemistry (1983) 1.30
Tautomeric composition of D-fructose phosphates in solution by Fourier transform carbon-13 nuclear magnetic resonance. Biochem Biophys Res Commun (1973) 1.16
Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J Infect Dis (1993) 1.14
Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology (1995) 1.08
Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol (1999) 1.01
Subcutaneous pancreatic fat necrosis associated with acute arthritis. J Rheumatol (1992) 0.99
Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect Immun (1998) 0.99
Hepatitis E virus infection prevalence among selected populations in Iowa. J Clin Virol (1999) 0.98
T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody. J Mol Cell Immunol (1985) 0.96
Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis (1995) 0.91
Chemical and carbon-13 nuclear magnetic resonance studies of the blood group M and N active sialoglycopeptides from human glycophorin A. J Biol Chem (1981) 0.88
Carbon 13 NMR spectroscopy of a cerebroside. Proof of the beta-pyranosyl structure of D-glucosylceramide. J Biol Chem (1979) 0.85
High-resolution proton NMR studies of gangliosides. 2. Use of two-dimensional nuclear Overhauser effect spectroscopy and sialylation shifts for determination of oligosaccharide sequence and linkage sites. Biochemistry (1983) 0.84
Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study. Transfusion (1996) 0.84
Transient blood plasmacytosis in parvovirus B19 infection: a report of two cases. Ann Hematol (1996) 0.84
Human parvovirus B19 infection and hepatitis. Lancet (1996) 0.84
Oligosaccharide structure by two-dimensional proton nuclear magnetic resonance spectroscopy. Methods Enzymol (1987) 0.83
Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease. Am J Pediatr Hematol Oncol (1989) 0.83
Detection in human blood platelets of sialyl Lewis X gangliosides, potential ligands for CD62 and other selectins. Glycobiology (1995) 0.82
Suppressor T-cell factor(s) display an altered pattern of Igh (immunoglobulin heavy chain locus) genetic restriction when developed in an Igh-congeneic host. Proc Natl Acad Sci U S A (1985) 0.81
A proposed model for the regulation of phosphofructokinase and fructose 1,6-bisphosphatase based on their reciprocal anomeric specificities. FEBS Lett (1977) 0.81
Structure of an extracellular polysaccharide produced by Erwinia chrysanthemi. Carbohydr Res (1993) 0.81
The role of xenoantigen in the human autologous mixed lymphocyte reaction: ability to respond in the absence of exposure to xenoantigen depends on the method of T-cell preparation. Clin Immunol Immunopathol (1985) 0.81
Feasibility and success of a single-donor red cell program for pediatric elective surgery patients. Transfusion (1992) 0.80
Effect of mode of agitation on storage of platelet concentrates in PL-732 containers for 5 days. Vox Sang (1983) 0.80
Fibromyalgia and parvovirus infection. Arthritis Rheum (1991) 0.79
Isolation and characterization of a novel phytosphingosine-containing GM2 ganglioside from mullet roe (Mugil cephalus). J Biol Chem (1984) 0.79
The fructose 6-phosphate site of phosphofructokinase. I. Tautomeric and anomeric specificity. J Biol Chem (1974) 0.79
Black tongue. Arch Dermatol (2001) 0.79
Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Am J Obstet Gynecol (1991) 0.78
The fructose 6-phosphate site of phosphofructokinase. Epimeric specificity. J Biol Chem (1976) 0.78
Carbon-13 nuclear magnetic resonance studies and anomeric composition of ketohexose phosphates in solution. Biochemistry (1980) 0.78
The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals. Transfusion (1998) 0.78
The 3G11+ antigen, a marker for murine CD4+ TH1 lymphocytes, is a ganglioside. Glycobiology (1993) 0.77
Human platelets express gangliosides with LKE activity and ABH blood group activity. Transfusion (2001) 0.77
Suppression of antigen-specific interleukin 2 production in the MRL/MpJ-lpr/lpr mouse. J Immunol (1986) 0.77
Fetal survival after human parvovirus B19 infection: spectrum of intrauterine response in a twin gestation. Am J Perinatol (1992) 0.77
Regulation of hapten-specific T-cell response. II. Functional analysis of helper T cells and cytotoxic T cells in animals suppressed by azobenzenearsonate (ABA)-specific suppressor T cells. Cell Immunol (1985) 0.77
Isolation and characterization of gangliosides with hybrid neolacto-ganglio-type sugar chains. J Biol Chem (1987) 0.77
Absence of parvovirus B19 infection in chronic fatigue syndrome. Arthritis Rheum (1995) 0.76
Elucidation of glycolipid structure by proton nuclear magnetic resonance spectroscopy. Chem Phys Lipids (1986) 0.76
Parvovirus b19 infection associated with acute hepatitis, arthralgias, and rash. J Clin Rheumatol (1996) 0.76
Evidence of a phospholipid binding species within human fibrinogen preparations. Thromb Res (1999) 0.76
Diagnosis of fetal infection in the patient with an ultrasonographically detected abnormality but a negative clinical history. Am J Obstet Gynecol (1993) 0.76
Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys. Transplantation (1993) 0.76
Idiopathic regional osteoporosis: a clinical spectrum. J Rheumatol (1985) 0.75
Aseptic meningitis caused by parvovirus B19. Clin Infect Dis (1995) 0.75
Established fibromyalgia syndrome and parvovirus B19 infection. J Rheumatol (1993) 0.75
Carbon-13 nuclear-magnetic-resonance spectroscopy of Forssman hapten. Biochem J (1981) 0.75
Human parvovirus B19 infection in children with new onset Type 1 diabetes mellitus. Diabet Med (2005) 0.75
Surrogate testing for AIDS. Transfusion (1995) 0.75
Two-dimensional 1H-, 13C-, and 31P-nuclear magnetic resonance and molecular-mechanics investigation of D-fructose 2,6-bisphosphate. Carbohydr Res (1990) 0.75
A combined pseudoreplica-immunochemical technique for research and diagnostic virology. Microsc Res Tech (1992) 0.75
Human parvovirus infection. Am Fam Physician (1989) 0.75
High-resolution proton NMR studies of gangliosides. III. Elucidation of the structure of ganglioside GM3 lactone. J Biochem (1985) 0.75
A quantitative analysis of H-2 linked effects on hepatic ganglioside composition. Immunogenetics (1987) 0.75
Donor reactions during DDAVP-stimulated plasmapheresis. J Clin Apher (1992) 0.75
Recent advances in structural analysis of gangliosides: primary and secondary structures. Adv Exp Med Biol (1984) 0.75
Platelet concentrates. Influence of different preparative protocols on the in vitro release reaction. Vox Sang (1982) 0.75
Serum volumes should not be reduced when testing neonates for unexpected red cell antibodies. Am J Clin Pathol (1990) 0.75
Extracellular polysaccharide of Erwinia chrysanthemi. Carbohydr Res (1995) 0.75
Pulmonary edema resulting from oxygen toxicity in divers. J La State Med Soc (1970) 0.75
Osmometry in the evaluation of alcohol intoxication. Clin Toxicol (1972) 0.75
Reassignment of the methine resonances of D-fructose based on the carbon-13 N.M.R. spectrum of 3-O-methyl-D-fructose. Biochem Biophys Res Commun (1978) 0.75
The effect of storage on the ganglioside content of human platelets. Transfusion (1986) 0.75
Glycosphingolipid inhibition of the adhesion of thrombin-activated platelets to surfaces is potentiated by albumin. Glycobiology (1993) 0.75
Characterization of human liver 3-O-beta-D-glucopyranuronosyl-cholesterol by mass spectrometry and nuclear magnetic resonance spectroscopy. J Lipid Res (1984) 0.75